These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Angiotensin II enhances the expression of Gialpha in A10 cells (smooth muscle): relationship with adenylyl cyclase activity. Palaparti A; Ge C; Anand-Srivastava MB Arch Biochem Biophys; 1999 May; 365(1):113-22. PubMed ID: 10222045 [TBL] [Abstract][Full Text] [Related]
5. Modulation of ANP-C receptor signaling by arginine-vasopressin in A-10 vascular smooth muscle cells: role of protein kinase C. Boumati M; Li Y; Anand-Srivastava MB Arch Biochem Biophys; 2003 Jul; 415(2):193-202. PubMed ID: 12831842 [TBL] [Abstract][Full Text] [Related]
6. Modulation of ANP-C receptor signaling by endothelin-1 in A-10 smooth muscle cells. Boumati M; Li Y; Anand-Srivastava MB Arch Biochem Biophys; 2002 May; 401(2):178-86. PubMed ID: 12054468 [TBL] [Abstract][Full Text] [Related]
7. Downregulation of atrial natriuretic peptide ANP-C receptor is associated with alterations in G-protein expression in A10 smooth muscle cells. Anand-Srivastava MB Biochemistry; 2000 May; 39(21):6503-13. PubMed ID: 10828966 [TBL] [Abstract][Full Text] [Related]
8. Ring-deleted analogs of atrial natriuretic factor inhibit adenylate cyclase/cAMP system. Possible coupling of clearance atrial natriuretic factor receptors to adenylate cyclase/cAMP signal transduction system. Anand-Srivastava MB; Sairam MR; Cantin M J Biol Chem; 1990 May; 265(15):8566-72. PubMed ID: 2160462 [TBL] [Abstract][Full Text] [Related]
13. Expression of guanylyl cyclase-A/atrial natriuretic peptide receptor blocks the activation of protein kinase C in vascular smooth muscle cells. Role of cGMP and cGMP-dependent protein kinase. Kumar R; Cartledge WA; Lincoln TM; Pandey KN Hypertension; 1997 Jan; 29(1 Pt 2):414-21. PubMed ID: 9039136 [TBL] [Abstract][Full Text] [Related]
14. In vitro and in vivo effects of UP 269-6, a new potent orally active nonpeptide angiotensin II receptor antagonist, on vascular smooth muscle cell proliferation. Virone-Oddos A; Desangle V; Provost D; Cazes M; Caussade F; Cloarec A Br J Pharmacol; 1997 Feb; 120(3):488-94. PubMed ID: 9031754 [TBL] [Abstract][Full Text] [Related]
15. Angiotensin II receptor recognized by DuP753 regulates two distinct guanine nucleotide-binding protein signaling pathways. Crawford KW; Frey EA; Cote TE Mol Pharmacol; 1992 Jan; 41(1):154-62. PubMed ID: 1310139 [TBL] [Abstract][Full Text] [Related]
16. Angiotensin II and atrial natriuretic factor receptor interactions at the blood-brain barrier. Grammas P; Giacomelli F; Bessert D; Wiener J Brain Res; 1991 Oct; 562(1):93-7. PubMed ID: 1686850 [TBL] [Abstract][Full Text] [Related]
17. BMS-180560, an insurmountable inhibitor of angiotensin II-stimulated responses: comparison with losartan and EXP3174. Dickinson KE; Cohen RB; Skwish S; Delaney CL; Serafino RP; Poss MA; Gu Z; Ryono DE; Moreland S; Powell JR Br J Pharmacol; 1994 Sep; 113(1):179-89. PubMed ID: 7812609 [TBL] [Abstract][Full Text] [Related]
18. Binding and signal transduction of the cloned vascular angiotensin II (AT1a) receptor cDNA stably expressed in Chinese hamster ovary cells. Webb ML; Monshizadegan H; Dickinson KE; Serafino R; Moreland S; Michel I; Seiler SM; Murphy TJ Regul Pept; 1993 Mar; 44(2):131-9. PubMed ID: 8469768 [TBL] [Abstract][Full Text] [Related]
19. Inhibition of atrial natriuretic peptide (ANP) C receptor expression by antisense oligodeoxynucleotides in A10 vascular smooth-muscle cells is associated with attenuation of ANP-C-receptor-mediated inhibition of adenylyl cyclase. Palaparti A; Li Y; Anand-Srivastava MB Biochem J; 2000 Mar; 346 Pt 2(Pt 2):313-20. PubMed ID: 10677348 [TBL] [Abstract][Full Text] [Related]
20. Angiotensin-II-induced enhanced expression of Gi proteins is attenuated by losartan in A10 vascular smooth muscle cells: role of AT1 receptors. Anand-Srivastava MB; Palaparti A Can J Physiol Pharmacol; 2003 Feb; 81(2):150-8. PubMed ID: 12710529 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]